Suchergebnisse - (Subject:"Ritonavir")

PubPharm (14)

1

Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study

enthalten in: AIDS patient care and STDs | 2012

von McDonald, C. | Uy, J. | Hu, W. | +6

2

Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients

enthalten in: AIDS patient care and STDs | 2011

von Wang, X. | Boffito, M. | Zhang, J. | +9

3

Single-tablet Quad regimen achieves high rate of virologic suppression

enthalten in: AIDS patient care and STDs | 2010

4

96-week CASTLE data show similar efficacy results

enthalten in: AIDS patient care and STDs | 2008

5

Intracranial hemorrhage and liver-associated deaths associated with tipranavir/ritonavir : review of cases from the FDA's Adverse Event Reporting System

enthalten in: AIDS patient care and STDs | 2008

von Chan-Tack, K. | Struble, K. | Birnkrant, D.

6

CASTLE study showed similar efficacy

enthalten in: AIDS patient care and STDs | 2008

7

Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients : the CARe Study

enthalten in: AIDS patient care and STDs | 2008

von Santoro, M. | Bertoli, A. | Lorenzini, P. | +14

8

Aptivus capsules granted full FDA approval

enthalten in: AIDS patient care and STDs | 2007

9

Tipranavir demonstrates potent and durable treatment response in HIV-positive women

enthalten in: AIDS patient care and STDs | 2007

10

Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent

enthalten in: AIDS patient care and STDs | 2007

von St Germain, R. | Yigit, S. | Wells, L. | +3

ErratumIn: AIDS Patient Care STDS. 2007 Jul;21(7):526 Giratto, Jennifer E [corrected to Girotto, Jennifer E]